(Q34138706)

English

Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

6

object named as

Nilesh Samani

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

object named as

Leong L Ng

5

0 references

author name string

Dominic Kelly

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sohail Q Khan

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Matt Thompson

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Gillian Cockerill

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Iain B Squire

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

8 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2116-2124

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Early predictors of left ventricular remodeling after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

5 July 2018

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941717

28 October 2018

Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormalities of the extracellular degradation of collagen type I in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of tissue inhibitors of metalloproteinases in the failing human heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18614523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EURHEARTJ/EHN315

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34138706&oldid=1601213794"